Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: an echocardiographic assessment

Abstract

Experience with terlipressin (TP) in the neonatal field is scarce. We describe the effects of TP on pulmonary circulation, studied with echocardiography, in an asphyxiated septic cooled infant with pulmonary hypertension (PH) who developed catecholamine-resistant hypotension and exacerbation of PH shortly after the beginning of the rewarming. TP was added to norephinephine and adrenaline infusions at the dose of 0.02 mg kg−1 every 6 h, because of refractory hypotension and oliguria. After 10 min, blood pressure dramatically and definitely increased, and urinary output was re-established after 60 min. Echocardiographic evaluation 30 min after the second bolus of TP showed unchanged velocity of the tricuspidal valve regurgitation and improved biventricular functional indexes respect to the pre-treatment assessment. TP was continued for 12 h (three doses) without significant adverse effect except for a transient increase in troponin levels. Addition of TP boluses to catecholamine infusion in our newborn was effective in increasing systemic vascular resistance without increasing pulmonary vascular resistance, successfully reversing the hemodynamics of severe PH, and suggesting a potential primary vasodilator effect on pulmonary circulation. Transient increase of troponin levels during TP treatment confirms the risk of excessive coronary vasoconstriction when TP boluses are added to high dose catecholamines.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Morelli A, Ertmer C, Pietropaoli P, Westphal M . Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother 2009; 10: 2569–2575.

    Article  CAS  Google Scholar 

  2. Gluud LL, Christensen K, Christensen E, Krag A . Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010; 51: 576–584.

    Article  CAS  Google Scholar 

  3. Filippi L, Gozzini E, Daniotti M, Pagliai F, Catarzi S, Fiorini P . Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med 2011; 12: 1–5.

    Article  Google Scholar 

  4. Filippi L, Poggi C, Serafini L, Fiorini P . Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 2008; 97: 500–502.

    Article  Google Scholar 

  5. Leone M, Martin C . Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. Best Pract Res Clin Anaesthesiol 2008; 22: 323–333.

    Article  CAS  Google Scholar 

  6. Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5: 116–118.

    Article  Google Scholar 

  7. Papoff P, Caresta E, Versacci P, Grossi R, Midulla F, Moretti C . The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Anesth 2009; 19: 805–806.

    Article  Google Scholar 

  8. Stathopoulos L, Nicaise C, Michel F, Thomachot L, Merrot T, Lagier P et al. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J Pediatr Surg 2011; 46: E19–E21.

    Article  Google Scholar 

  9. Pesaturo AB, Jennings HR, Voils SA . Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother 2006; 40: 2170–2177.

    Article  CAS  Google Scholar 

  10. Westphal M, Stubbe H, Sielenkämper AW, Borgulya R, Van Aken H, Ball C et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29: 301–308.

    Article  Google Scholar 

  11. Westphal M, Stubbe H, Sielenkämper AW, Ball C, Van Aken H, Borgulya R et al. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003; 31: 1502–1508.

    Article  CAS  Google Scholar 

  12. Albanèse J, Leone M, Delmas A, Martin C . Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005; 33: 1897–1902.

    Article  Google Scholar 

  13. Torgersen C, Dünser MW, Wenzel V, Jochberger S, Mayr V, Schmittinger CA et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med 2010; 36: 57–65.

    Article  CAS  Google Scholar 

  14. Lange M, Ertmer C, Westphal M . Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008; 34: 821–832.

    Article  CAS  Google Scholar 

  15. Scheurer MA, Scott MB, Atz AM . Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J Thorac Cardiovasc Surg 2005; 129: 464–466.

    Article  Google Scholar 

  16. Price LC, Forrest P, Sodhi V, Adamson DL, Nelson-Piercy C, Lucey M et al. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007; 99: 552–555.

    Article  CAS  Google Scholar 

  17. Kalambokis GN, Pappas K, Tsianos EV . Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study. Angiology; e-pub ahead of print 6 July 2011.

  18. Skinner JR, Boys RJ, Heads A, Hey EN, Hunter S . Estimation of pulmonary arterial pressure in the newborn: study of the repeatability of four Doppler echocardiographic techniques. Pediatr Cardiol 1996; 17: 360–369.

    Article  CAS  Google Scholar 

  19. Chemla D, Lambert V, Losay J . Mean pulmonary artery pressure estimated from systolic and diastolic pulmonary artery pressure in children with congenital heart disease: an invasive study. Pediatr Cardiol 2009; 30: 1137–1142.

    Article  Google Scholar 

  20. Kluckow M . Functional echocardiography in assessment of the cardiovascular system in asphyxiated neonates. J Pediatr 2011; 158: e13–e18.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Radicioni.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radicioni, M., Troiani, S. & Camerini, P. Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: an echocardiographic assessment. J Perinatol 32, 893–895 (2012). https://doi.org/10.1038/jp.2011.181

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2011.181

Keywords

This article is cited by

Search

Quick links